Phase II Clinical Trial to evaluate the efficacy of silibinin supplementation in the prevention of the progression of the respiratory failure in patients with onco-hematological diseases and infection by COVID-19 positive.
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Silibinin (Primary)
- Indications COVID 2019 infections; Respiratory insufficiency
- Focus Therapeutic Use
- Acronyms SilCOVID19
- 29 Jul 2020 New trial record